We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

State-of-the-Art Software Controls New Microscope Imagining System

By LabMedica International staff writers
Posted on 25 Aug 2011
Two bioscience companies have combined their expertise to create a high performance imaging system particularly suitable for cellular analysis studies.

Leica Microsystems (Wetzlar, Germany) and Molecular Devices (Sunnyvale, CA, USA) have announced the launch of their new Leica MM AF NX imaging system. This system brings together Leica Microsystems’ leading microscopy technology and Molecular Devices’ latest MetaMorph NX Software.

MetaMorph Software provides all the tools needed to perform meaningful analysis of images acquired by the Leica microscope. Common tools for thresholding, filtering, and feature extraction are included as well as other more sophisticated tools such as the integrated morphometry analysis (IMA) module. IMA allows objects to be measured and separated into user-definable classes, based on any combination of measured morphometric parameters, such as shape, size, or optical density. A point-and-click interface, linking images and spreadsheet results, makes it easy to choose representative objects for classification and measurement. All displayed images can be zoomed, paned, or scaled to any bit depth and colors can be assigned to channels for further investigation. Furthermore, the system automatically saves acquired images as well as measurement results, which can be accessed, reconfigured, and filtered at any time.

“The new Leica MM AF NX extends our offering of user-friendly and workflow-oriented imaging platforms like the Leica LAS AF software for sophisticated fluorescence applications,” said Sebastian Tille, head of the business segment at Leica Microsystems. “This evidences the fruitful collaboration between Molecular Devices and Leica Microsystems, in which the strengths of both companies complement one another.”

Related Links:
Leica Microsystems
Molecular Devices




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
25 Aug 2011  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
25 Aug 2011  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
25 Aug 2011  |   BioResearch